| [April 14, 2010] |
 |
BIOTRONIK adds New "Reocor" External Pacemaker to its High-Quality Product Portfolio
BERLIN --(Business Wire)--
BIOTRONIK SE & Co. KG today announced the European launch after
receiving CE Mark approval for its new Reocor external
pacemakers, available in two models for dual and single chamber
pacing therapy.
Quality based on 25 years of experience
BIOTRONIK continues
to enrich its high quality product portfolio with the launch of the new
external pacemakers. Reocor offers complete reliability in emergencies
and temporary patient care, setting a new quality standard for external
pacing therapy.
Reocor - Intuitive design for safe usage in daily practice
The
new Reocor has an intuitive design for simplified usage and extended
longevity that increases reliability and reduces costs over time.
Simplified usage is achieved by the function dials displaying selectable
parameter values and visualizing programmed settings at a glance. Thus,
easy handling is guaranteed without any specific training requirements.
Extended battery service times f up to 25 days for permanent pacing
therapy, supplemented with a backup power supply during battery
replacement, ensure patient safety and longer continuous usage in daily
practice. Reocor has also been enhanced to accommodate high pacing
outputs and high pacing rates being especially important for pediatric
care. Therefore Reocor effectively delivers individual solutions for a
broad range of patients.
"Reocor represents the first in a series of advanced new external
devices that BIOTRONIK will launch. In 2010 we will be offering a new
external pacemaker, a new pacing system analyzer and a completely new
programmer which demonstrates our commitment to develop the highest
quality and the most complete CRM product portfolio. Reocor represents
the ultimate promise of reliability to our customers with clear
advantages in its ease of use, unsurpassed longevity, and convenient
mobility in a small and lightweight housing," stated Marlou Janssen,
Vice President, Global Marketing and Sales, Cardiac Rhythm Management,
BIOTRONIK.
About BIOTRONIK SE & Co. KG
As one of the world's
leading manufacturers of cardiovascular medical devices, with several
million devices implanted, BIOTRONIK is represented in over 100
countries by its global workforce of more than 5,100 employees. Known
for having its finger on the pulse of the medical community, BIOTRONIK
assesses the challenges physicians face, and provides the best solutions
for all phases of patient care, ranging from diagnosis to treatment to
patient management. Quality, innovation and reliability define BIOTRONIK
and its growing success, and deliver confidence and peace of mind to
physicians and their patients worldwide.
More information: www.biotronik.com
Upon publication, please provide us with a copy.
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
